Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Neurobiol Aging ; 36(2): 648-63, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25293421

RESUMO

Amyloid-ß (Aß) fragments, oligomeric Aß aggregates, and pyroglutamylated-Aß peptides, as well as epigenetic mechanisms and autophagy dysfunction all appear to contribute in various ways to Alzheimer's disease progression. We previously showed that dietary supplementation of oleuropein aglycone, a natural phenol abundant in the extra virgin olive oil, can be protective by reducing Aß42 deposits in the brain of young and middle-aged TgCRND8 mice. Here, we extended our study to aged TgCRND8 mice showing increased pE3-Aß in the brain deposits. We report that oleuropein aglycone is active against glutaminylcyclase-catalyzed pE3-Aß generation reducing enzyme expression and interferes both with Aß42 and pE3-Aß aggregation. Moreover, the phenol astonishingly activates neuronal autophagy even in mice at advanced stage of pathology, where it increases histone 3 and 4 acetylation, which matches both a decrease of histone deacetylase 2 expression and a significant improvement of synaptic function. The occurrence of these functional, epigenetic, and histopathologic beneficial effects even at a late stage of the pathology suggests that the phenol could be beneficial at the therapeutic, in addition to the prevention, level.


Assuntos
Doença de Alzheimer/etiologia , Peptídeos beta-Amiloides/metabolismo , Peptídeos beta-Amiloides/toxicidade , Encéfalo/metabolismo , Epigênese Genética , Iridoides/farmacologia , Iridoides/uso terapêutico , Fragmentos de Peptídeos/metabolismo , Fragmentos de Peptídeos/toxicidade , Agregados Proteicos/efeitos dos fármacos , Doença de Alzheimer/tratamento farmacológico , Doença de Alzheimer/prevenção & controle , Animais , Autofagia/efeitos dos fármacos , Depressão Química , Suplementos Nutricionais , Progressão da Doença , Feminino , Histona Desacetilase 2/metabolismo , Histonas/metabolismo , Glucosídeos Iridoides , Masculino , Camundongos Transgênicos , Azeite de Oliva , Óleos de Plantas/química
2.
Neurodegener Dis ; 13(2-3): 131-4, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24192327

RESUMO

BACKGROUND: Translational research needs valid animal models of disease to discover new pathogenetic aspects and treatments. In Alzheimer's disease (AD), transgenic models are of great value for AD research and drug testing. OBJECTIVE: It was the aim of this study to analyze the power of dietary polyphenols against neurodegeneration by investigating the effects of oleuropein aglycone (OLE), the main phenol in the extra virgin olive oil (EVOO), a key component of the Mediterranean diet (MD), in a mouse model of amyloid-ß deposition. METHODS: TgCRND8 mice (3.5 months old), expressing the mutant KM670/671NL+V717F h-ßAPP695 transgene, and wild-type (wt) mice were used to study in vivo the effects of an 8-week dietary supplementation with OLE (50 mg/kg of diet) [Grossi et al: PLoS One 2013;8:e71702], following the European Communities Council Directive 86/609 (DL 116/92) and National Guidelines (permit number: 283/2012-B). RESULTS: OLE administration ameliorates memory dysfunction, raises a significant autophagic response in the cortex and promotes the proliferation of newborn cells in the subgranular zone of the dentate gyrus of the hippocampus. CONCLUSIONS: Our findings support the beneficial effects of EVOO and highlight the possibility that continuous intake of high doses of OLE, both as a nutraceutical or as a food integrator, may prevent/delay the appearance of AD and reduce the severity of its symptoms.


Assuntos
Doença de Alzheimer/patologia , Encéfalo/patologia , Dieta Mediterrânea , Iridoides/farmacologia , Fármacos Neuroprotetores/farmacologia , Ração Animal , Animais , Modelos Animais de Doenças , Humanos , Glucosídeos Iridoides , Camundongos Transgênicos , Azeite de Oliva , Óleos de Plantas/química , Pesquisa Translacional Biomédica
3.
Neurosci Lett ; 558: 67-72, 2014 Jan 13.
Artigo em Inglês | MEDLINE | ID: mdl-24211687

RESUMO

Previous data have shown that oleuropein aglycone (OLE), the main secoiridoid phenol present in extra virgin olive oil, counteracts in vitro aggregation of the Aß42 peptide and protects cultured cells and model organisms against aggregates toxicity. In this study we investigated the relative tissue toxicity of Aß42 aggregated in vitro in the presence or in the absence of OLE by injecting the nucleus basalis magnocellularis (NBM) of adult male Wistar rats with a 1.5 µl solution containing OLE (450 µM) or Aß42 (50 µM) aggregated in the absence (oligomers) or in the presence of 450 µM OLE. Control rats were injected with vehicle (1.5 µl). Thirty days after injection, the number of choline acetyltransferase (ChAT)-positive neurons, glia reaction and the Aß peptide levels were detected by immunohistochemistry. An apparent reduction in the amount of soluble A11-positive oligomers was detected in the NBM injected with Aß42 aggregated with OLE, as compared with the NBM injected with Aß42 alone. In the latter case, the number of ChAT-positive neurons was significantly reduced (≈-33%) respect to that recorded in the NBM injected with phosphate buffer, OLE or Aß42 aggregated with OLE. A markedly attenuated Aß-induced astrocytes and microglia reaction was also found in the NBM injected with Aß42 aggregated with OLE. Altogether, these data provide additional support to the anti-aggregation, neuroprotective and anti-inflammatory activities of this natural phenol, confirming its beneficial properties against neurodegeneration.


Assuntos
Peptídeos beta-Amiloides/metabolismo , Encéfalo/efeitos dos fármacos , Iridoides/farmacologia , Fármacos Neuroprotetores/farmacologia , Fragmentos de Peptídeos/metabolismo , Piranos/farmacologia , Peptídeos beta-Amiloides/toxicidade , Animais , Núcleo Basal de Meynert/efeitos dos fármacos , Núcleo Basal de Meynert/metabolismo , Núcleo Basal de Meynert/patologia , Encéfalo/metabolismo , Encéfalo/patologia , Glucosídeos Iridoides , Masculino , Neuroglia/metabolismo , Neuroglia/patologia , Neurônios/metabolismo , Neurônios/patologia , Fragmentos de Peptídeos/toxicidade , Ratos Wistar
4.
PLoS One ; 8(8): e71702, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23951225

RESUMO

The claimed beneficial effects of the Mediterranean diet include prevention of several age-related dysfunctions including neurodegenerative diseases and Alzheimer-like pathology. These effects have been related to the protection against cognitive decline associated with aging and disease by a number of polyphenols found in red wine and extra virgin olive oil. The double transgenic TgCRND8 mice (overexpressing the Swedish and Indiana mutations in the human amyloid precursor protein), aged 1.5 and 4, and age-matched wild type control mice were used to examine in vivo the effects of 8 weeks dietary supplementation of oleuropein aglycone (50 mg/kg of diet), the main polyphenol found in extra virgin olive oil. We report here that dietary supplementation of oleuropein aglycone strongly improves the cognitive performance of young/middle-aged TgCRND8 mice, a model of amyloid-ß deposition, respect to age-matched littermates with un-supplemented diet. Immunofluorescence analysis of cerebral tissue in oleuropein aglycone-fed transgenic mice showed remarkably reduced ß-amyloid levels and plaque deposits, which appeared less compact and "fluffy"; moreover, microglia migration to the plaques for phagocytosis and a remarkable reduction of the astrocyte reaction were evident. Finally, oleuropein aglycone-fed mice brain displayed an astonishingly intense autophagic reaction, as shown by the increase of autophagic markers expression and of lysosomal activity. Data obtained with cultured cells confirmed the latter evidence, suggesting mTOR regulation by oleuropein aglycone. Our results support, and provide mechanistic insights into, the beneficial effects against Alzheimer-associated neurodegeneration of a polyphenol enriched in the extra virgin olive oil, a major component of the Mediterranean diet.


Assuntos
Precursor de Proteína beta-Amiloide/genética , Precursor de Proteína beta-Amiloide/metabolismo , Encéfalo/efeitos dos fármacos , Encéfalo/patologia , Polifenóis/farmacologia , Piranos/farmacologia , Animais , Autofagia/efeitos dos fármacos , Encéfalo/metabolismo , Linhagem Celular , Cognição/efeitos dos fármacos , Suplementos Nutricionais/análise , Feminino , Humanos , Glucosídeos Iridoides , Iridoides , Masculino , Transtornos da Memória/tratamento farmacológico , Transtornos da Memória/genética , Transtornos da Memória/metabolismo , Transtornos da Memória/patologia , Camundongos , Camundongos Transgênicos , Mutação , Azeite de Oliva , Óleos de Plantas/química , Polifenóis/química , Piranos/química , Serina-Treonina Quinases TOR/metabolismo
5.
Neurobiol Aging ; 34(9): 2100-9, 2013 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23601807

RESUMO

Protein misfolded oligomers are thought to be the primary pathogenic species in many protein deposition diseases. Oligomers by the amyloid-ß peptide play a central role in Alzheimer's disease pathogenesis, being implicated in synaptic dysfunction. Here we show that the oligomers formed by a protein that has no link with human disease, namely the N-terminal domain of HypF from Escherichia coli (HypF-N), are also synaptotoxic. HypF-N oligomers were found to (i) colocalize with post-synaptic densities in primary rat hippocampal neurons; (ii) induce impairment of long-term potentiation in rat hippocampal slices; and (iii) impair spatial learning of rats in the Morris Water Maze test. By contrast, the native protein and control nontoxic oligomers had none of such effects. These results raise the importance of using HypF-N oligomers as a valid tool to investigate the pathogenesis of Alzheimer's disease, with advantages over other systems for their stability, reproducibility, and costs. The results also suggest that, in the context of a compromised protein homeostasis resulting from aggregation of the amyloid ß peptide, a number of oligomeric species sharing common synaptotoxic activity can arise and cooperate in the pathogenesis of the disease.


Assuntos
Doença de Alzheimer/genética , Peptídeos beta-Amiloides/química , Peptídeos beta-Amiloides/toxicidade , Carboxil e Carbamoil Transferases/química , Carboxil e Carbamoil Transferases/toxicidade , Proteínas de Escherichia coli/química , Proteínas de Escherichia coli/toxicidade , Hipocampo/efeitos dos fármacos , Neurônios/efeitos dos fármacos , Sinapses/efeitos dos fármacos , Aglutinação , Animais , Células Cultivadas , Hipocampo/fisiopatologia , Humanos , Potenciação de Longa Duração/efeitos dos fármacos , Masculino , Neurônios/fisiologia , Fragmentos de Peptídeos , Densidade Pós-Sináptica/efeitos dos fármacos , Multimerização Proteica , Ratos , Ratos Wistar , Relação Estrutura-Atividade
6.
Neurosci Lett ; 506(1): 94-9, 2012 Jan 06.
Artigo em Inglês | MEDLINE | ID: mdl-22056484

RESUMO

The purpose of this study was to investigate the microglia-driven apoptosis and the Aß deposits triggered generation of new microglial cells in the neocortex of TgCRND8 mice. Three- and seven-month-old TgCRND8 mice, displaying an early and widespread amyloid deposition, respectively, were used. In 7-month-old TgCRND8 mice the Aß-associated glial reaction was accompanied by an intense immunoreactivity of both TNF-α and inducible nitric oxide synthase, increased immunoreactivity of the pro-apoptotic protein Bax and a decrease in levels of the anti-apoptotic protein Bcl-2.Cortical and hippocampal neurons of TgCRND8 mice displayed higher immunoreactivity and higher nuclear expression of the transcription factor NF-kB than controls. It is possible that such an increase could represent a defence/compensatory response to degeneration. These findings indicate that Aß deposits activate brain-resident microglia population and astrocytes, and induce overproduction of inflammatory mediators that enhance pro- and anti-apoptotic cascades. In both 3- and 7-month-old TgCRND8 mice apparent gliogenesis was present in the vicinity of Aß plaques in the neocortex, indicating that microglia have a high proliferative rate which might play a more complex role than previously acknowledge.


Assuntos
Doença de Alzheimer/patologia , Doença de Alzheimer/fisiopatologia , Apoptose/genética , Córtex Cerebral/patologia , Neuroglia/fisiologia , Placa Amiloide/patologia , Fatores Etários , Doença de Alzheimer/genética , Precursor de Proteína beta-Amiloide/genética , Animais , Bromodesoxiuridina/metabolismo , Proteínas de Ligação ao Cálcio/metabolismo , Proliferação de Células , Modelos Animais de Doenças , Regulação da Expressão Gênica/genética , Proteína Glial Fibrilar Ácida/metabolismo , Humanos , Camundongos , Camundongos Transgênicos , Proteínas dos Microfilamentos/metabolismo , Mutação/genética , Neurônios/fisiologia , Óxido Nítrico Sintase Tipo II/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...